fbpx
Medical Innovation Exchange

Amgen hits pause on $400M eczema bet to tweak phase 3 study

https://www.fiercebiotech.com/biotech/amgen-hits-pause-400m-eczema-bet-tweak-phase-3-study

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.